13F-HR filed by Lion Point Capital, LP
Lion Point Capital, LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 24 holding rows worth $1,106,549,000.
- Accession
- 0001567619-19-011210
- Filer
- CIK 1643354
- Filed
- 2019-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, 24 entries on the cover page, a total value of $1,106,549,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,106,549,000 with VALUE read as thousands by filing date, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 464287655 | SHS | 2,835,000 | $434,010,000 | thousands by filing date | put |
| LATTICE SEMICONDUCTOR CORP COM | 518415104 | Stock | 7,858,195 | $93,748,000 | thousands by filing date | |
| CANADIAN SOLAR INC | 136635109 | COM | 4,636,826 | $86,384,000 | thousands by filing date | |
| PDC ENERGY INC | 69327R101 | COM | 1,547,180 | $62,939,000 | thousands by filing date | |
| CARRIZO OIL & GAS INC | 144577103 | COM | 4,344,400 | $54,174,000 | thousands by filing date | |
| SPDR SERIES TRUST | 78464A730 | S&P OILGAS EXP | 1,750,000 | $53,795,000 | thousands by filing date | put |
| ALDER BIOPHARMACEUTICALS INC | 014339AA3 | NOTE 2.500% 2/0 | 52,517,000 | $50,131,000 | thousands by filing date | principal |
| ALCOA CORP COM | 013872106 | Stock | 1,431,263 | $40,304,000 | thousands by filing date | |
| COMSCORE INC | 20564W105 | COM | 1,922,241 | $38,925,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,244,185 | $36,467,000 | thousands by filing date | |
| XILINX INC | 983919101 | COM | 265,000 | $33,599,000 | thousands by filing date | put |
| ARCONIC INC | 03965L100 | COM | 1,350,000 | $25,798,000 | thousands by filing date | |
| EQT CORP COM | 26884L109 | Stock | 1,036,450 | $21,495,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 1,271,500 | $17,355,000 | thousands by filing date | |
| FTS INTERNATIONAL INC | 30283W104 | COM | 1,656,826 | $16,568,000 | thousands by filing date | |
| ENCANA CORP | 292505104 | COM | 1,497,330 | $10,840,000 | thousands by filing date | |
| ZAYO GROUP HLDGS INC COM | 98919V105 | Stock | 282,000 | $8,014,000 | thousands by filing date | |
| EXTREME NETWORKS INC | 30226D106 | COM | 811,835 | $6,080,000 | thousands by filing date | |
| LOGICBIO THERAPEUTICS INC | 54142F102 | COM | 500,000 | $4,940,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 150,000 | $4,192,000 | thousands by filing date | |
| HORIZON PHARMA INVT LTD | 44052TAB7 | NOTE 2.500% 3/1 | 3,000,000 | $3,411,000 | thousands by filing date | principal |
| XPO INC COM | 983793100 | Stock | 46,000 | $2,472,000 | thousands by filing date | |
| OPES ACQUISITION CORP | 68373P209 | UNIT 03/07/2023 | 83,438 | $865,000 | thousands by filing date | |
| KEANE GROUP INC | 48669A108 | COM | 4,000 | $43,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-19-011210 | this filing | 2019-05-15 | acceptance time not in the bulk data set |